Clinical TrialsSearch results
Number of results: 819
Not yet recruiting
- Safety, tolerability, and pharmacokinetics of single rising oral doses of BI 1839100 in healthy male subjects (single-blind, randomised, placebo-controlled, parallel group design)
- -
- - -
- 2023-06-25
Not yet recruiting
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD9550 in Overweight and Obese Participants with T2DM.
- Non-alcoholic Steatohepatitis (NASH)
- Kinumura Takumi
- 2024-05-20
Not yet recruiting
- Single and Multiple Dose Study of MK-7480 in Healthy Japanese Participants
- Nonalcoholic fatty liver disease
- Tanaka Yoshiyuki
- 2024-05-22
Not yet recruiting
- Single ascending dose and multiple ascending dose study of M132101 in healthy subjects.
- infantile hemangioma
- Nishiura Tomoyuki
- 2024-02-08
Not yet recruiting
- Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naive Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
- Metastatic Colorectal Cancer
- Nakatani Iwami
- 2024-04-25
Not yet recruiting
- Study of efficacy and safety of dapagliflozin with CKD patients without diabetes and proteinuria
- Chronic kidney disease G3A1, A2
- Fukami Kei
- 2022-07-05
Not yet recruiting
- The Relative Bioavailability and Dose Linearity of Budesonide in Healthy Adult Japanese and Non-Asian Subjects
- primary immunoglobulin A nephropathy (IgAN)
- Kamimoto Masato
- 2024-05-16
Not yet recruiting
- Treatment Alternatives for Drug-naïve Schizophrenia in Japan
- Schizophrenia
- Resarch enforcement group, Japanese Sciety of Clinical Neuropsychopharmacology
- 2009-07-21
Other
- A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone for steroid-resistant nephrotic syndrome in children: A randomized controlled study
- Steroid-resistant nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2005-08-01
Other
- A combination of methylprednisolone and prednisolone and a combination of Methylprednisolone, prednisolone and mizoribine for systemic lupus erythematosus in children: A randomized controlled trial of efficacy and safety izolibin for (JSRDC04)
- systematic lupus erythematosus
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01